Current Issue cover

Recent in Regulatory (page 8 of 40)

[update] EU Classifies TiO2 as 'Suspected' Carcinogen by Inhalation

Update: It's official. European legislators are moving forward with the proposal to classify TiO2 as a suspected Category 2 carcinogen by inhalation. The could spell trouble for sunscreen developers.

[Update] Purisys Touts Descheduling Under Farm Bill

Tim Jones, vice president of global API and OTC for Purisys, claimed, “Descheduling means our customers no longer need DEA registrations to work with Purisys materials.”

Gregg Renfrew of Beautycounter to Testify in Cosmetic Reform Hearing

“It's been over 80 years since Congress has passed comprehensive legislation that would protect consumers from harmful ingredients in personal-care and beauty products," said Beautycounter founder and CEO Gregg Renfrew.

U.S. FDA Issues 15 Warning Letters Over CBD Products

“We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe," said FDA principal deputy commissioner Amy Abernethy, M.D., Ph.D.

Back to Basics IV: Product Labeling, Manufacturing and Launch

The development of a new cosmetic product is an extensive, multistep process, from idea generation to market launch. This fourth article in a series explores the rules for later steps in the process: claims, labeling and manufacturing. Click through to the digital magazine for more.

Proposed 'Natural Cosmetics Act' Gains Traction with Indies

Could it finally be time that U.S. legislators ante up with a definition for "natural" cosmetics? The bill has been proposed, and indie brands are backing it—naturally.

FTC Hits Sunday Riley with Violations for Faked Sephora Reviews

“Dishonesty in the online marketplace harms shoppers, as well as firms that play fair and square,” said Andrew Smith, director of the FTC’s Bureau of Consumer Protection.

FDA Alert: New J&J Baby Powder Recall

According to the FDA, a test sample from one lot was found to contain chrysotile fibers, a type of asbestos. As such, Oct. 18, 2019, Johnson & Johnson voluntarily recalled the product.

A Closer Look at Cosmetic Claims

Claims cannot be considered legal unless they are truthful, and truthfulness requires evidence, which needs to be honest. Theresa Callaghan, Ph.D., explores these laws and the relationship between claims and consumers in a new book.

DSM Seeks FDA Sunscreen Monograph Approval of Bemotrizinol

DSM believes it is important for consumers in the USA to benefit from the efficacy and aesthetics that modern filters such as BEMT can provide. As such, the company is pushing for Monograph status.

Could the FDA Sunscreen Monograph See a New Addition?

It's been decades since the FDA's OTC Sunscreen Monograph welcomed a new addition; back then, it was avobenzone. Now, another could be joining the ranks.

EPA Eyes 20 Chemicals for High Priority Risk Evaluation, ACC Responds

"EPA is providing a 90-day comment period during which interested persons may provide comments on the proposed designations of High-Priority Substances for risk evaluation." Read on to learn more.

Can't find what you're looking for? Try searching, or looking through past issues.